Anticorps GTPase HRAS

16 produits

GTPase HRAS est un gène codé par le symbole HRAS. Communément appelé aussi: H-Ras-1; Ha-Ras; Transforming protein p21; c-H-ras; p21ras; HRAS; HRAS1. GTPase HRAS a une masse de 21.3kDa, une longueur d'acide aminé de 189, et est impliqué dans les maladies: Costello syndrome; Congenital myopathy with excess of muscle spindles; Thyroid cancer, non-medullary, 2; Bladder cancer; Schimmelpenning-Feuerstein-Mims syndrome.

Nous proposons 16 des anticorps contre GTPase HRAS, élevé dans Lapin et Souris, qui sont appropriés pour le WB, IHC, ELISA, ICC/IF et IP avec des échantillons dérivés de Humain, Souris, Rat et Poulet.

Informations sur les Gènes et les Protéines

Résumé UniProt
Involved in the activation of Ras protein signal transduction (PubMed:22821884). Ras proteins bind GDP/GTP and possess intrinsic GTPase activity (PubMed:12740440, PubMed:14500341, PubMed:9020151).
Résumé Entrez
This gene belongs to the Ras oncogene family, whose members are related to the transforming genes of mammalian sarcoma retroviruses. The products encoded by these genes function in signal transduction pathways. These proteins can bind GTP and GDP, and they have intrinsic GTPase activity. This protein undergoes a continuous cycle of de- and re-palmitoylation, which regulates its rapid exchange between the plasma membrane and the Golgi apparatus. Mutations in this gene cause Costello syndrome, a disease characterized by increased growth at the prenatal stage, growth deficiency at the postnatal stage, predisposition to tumor formation, cognitive disability, skin and musculoskeletal abnormalities, distinctive facial appearance and cardiovascular abnormalities. Defects in this gene are implicated in a variety of cancers, including bladder cancer, follicular thyroid cancer, and oral squamous cell carcinoma. Multiple transcript variants, which encode different isoforms, have been identified for this gene.
Spécificité tissulaire
Widely expressed.
Implication dans la maladie
Costello syndrome: A rare condition characterized by prenatally increased growth, postnatal growth deficiency, mental retardation, distinctive facial appearance, cardiovascular abnormalities (typically pulmonic stenosis, hypertrophic cardiomyopathy and/or atrial tachycardia), tumor predisposition, skin and musculoskeletal abnormalities.

Congenital myopathy with excess of muscle spindles: Variant of Costello syndrome.

Thyroid cancer, non-medullary, 2: A form of non-medullary thyroid cancer (NMTC), a cancer characterized by tumors originating from the thyroid follicular cells. NMTCs represent approximately 95% of all cases of thyroid cancer and are classified into papillary, follicular, Hurthle cell, and anaplastic neoplasms.

Bladder cancer: A malignancy originating in tissues of the urinary bladder. It often presents with multiple tumors appearing at different times and at different sites in the bladder. Most bladder cancers are transitional cell carcinomas that begin in cells that normally make up the inner lining of the bladder. Other types of bladder cancer include squamous cell carcinoma (cancer that begins in thin, flat cells) and adenocarcinoma (cancer that begins in cells that make and release mucus and other fluids). Bladder cancer is a complex disorder with both genetic and environmental influences.

Schimmelpenning-Feuerstein-Mims syndrome: A disease characterized by sebaceous nevi, often on the face, associated with variable ipsilateral abnormalities of the central nervous system, ocular anomalies, and skeletal defects. Many oral manifestations have been reported, not only including hypoplastic and malformed teeth, and mucosal papillomatosis, but also ankyloglossia, hemihyperplastic tongue, intraoral nevus, giant cell granuloma, ameloblastoma, bone cysts, follicular cysts, oligodontia, and odontodysplasia. Sebaceous nevi follow the lines of Blaschko and these can continue as linear intraoral lesions, as in mucosal papillomatosis.
Similitudes de séquence
Belongs to the small GTPase superfamily. Ras family.
Modification post-traductionnelle
Palmitoylated by the ZDHHC9-GOLGA7 complex. A continuous cycle of de- and re-palmitoylation regulates rapid exchange between plasma membrane and Golgi.
Localisation cellulaire
Cell membrane. Golgi apparatus. Golgi apparatus membrane.

The active GTP-bound form is localized most strongly to membranes than the inactive GDP-bound form (By similarity). Shuttles between the plasma membrane and the Golgi apparatus.
Western Blot - Anti-GTPase HRAS Antibody (A15964) - Antibodies.com
(3)
Western Blot - Anti-GTPase HRAS Antibody (A81138) - Antibodies.com
(2)
Western Blot - Anti-GTPase HRAS Antibody [ARC0098] (A305855) - Antibodies.com
(2)
Antibodies.com Image Placeholder - Discover more for less
Western Blot - Anti-GTPase HRAS Antibody (A304841) - Antibodies.com
Anti-GTPase HRAS Antibody from FabGennix (P21RAS-121AP) - Antibodies.com
(2)
Antibodies.com Image Placeholder - Discover more for less
Antibodies.com Image Placeholder - Discover more for less
Antibodies.com Image Placeholder - Discover more for less
Antibodies.com Image Placeholder - Discover more for less
Antibodies.com Image Placeholder - Discover more for less
Antibodies.com Image Placeholder - Discover more for less
Antibodies.com Image Placeholder - Discover more for less
Antibodies.com Image Placeholder - Discover more for less
GTPase Hras Polyclonal Antibody from Signalway Antibody (42595) - Antibodies.com
Antibodies.com Image Placeholder - Discover more for less

Affichage de 1-16 sur 16 produits

Filtres Menu Principal Nous Contacter 0Caisse
Haut